Pharmacological Effects of a Specific Leukotriene B4 Receptor Antagonist (VML 295) on Blood Leukocytes, Cutaneous Inflammation and Epidermal Proliferation

VML 295 (LY 293111) is a potent and specific leukotriene 4 receptor antagonist. It has previously been shown in human volunteers that VML 295 at a dosage of 48 mg twice daily inhibits the ex vivo leukotriene B 4 (LTB 4 )-induced upregulation of CD11b on peripheral blood neutrophils. A clear dose-res...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Skin pharmacology and physiology 2000-03, Vol.13 (2), p.75-85
Hauptverfasser:	Seegers, Bianca A.M.P.A., Andriessen, Monique P.M., van Hooijdonk, Candida A.E.M., de Bakker, Els S.M., van Vlijmen-Willems, Ivonne M.J.J., Parker, Gerry L., van Erp, Piet E.J., van de Kerkhof, Peter C.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Original Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!